Genetically engineering a treatment for incurable brain tumors

Scientists are developing and validating a patent-pending novel immunotherapy to be used against glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.

https://www.sciencedaily.com/releases/2024/04/240422120626.htm